Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Axicabtagene ciloleucel vs standard‑of‑care therapy for relapsed/refractory larg...
Dr Frederick Locke - Moffitt Cancer Centre, Tampa, USA
Axicabtagene ciloleucel vs standard‑of‑care therapy for relapsed/refractory large B-cell lymphoma ( Dr Frederick Locke - Moffitt Cancer Centre, Tampa, USA )
13 Dec 2021
Dara-CVRd, V-ASCT and Dara-Vrd Consolidation in UHiR NDMM and pPCL compared with...
Dr Martin Kaiser - The Institute of Cancer Research, London UK
Dara-CVRd, V-ASCT and Dara-Vrd Consolidation in UHiR NDMM and pPCL compared with myeloma XI/XI+ Trial treatment for Uhir MM ( Dr Martin Kaiser - The Institute of Cancer Research, London  UK )
12 Dec 2021
Monoclonal antibody-based quadruplet therapy, AHCT and MRD response-adapted cons...
Prof Luciano Costa - University of Alabama at Birmingham, Birmingham, USA
Monoclonal antibody-based quadruplet therapy, AHCT and MRD response-adapted consolidation therapy gives highest rate of MRD negativity in NDMM ( Prof Luciano Costa - University of Alabama at Birmingham, Birmingham, USA )
12 Dec 2021
Lisocabtagene maraleucel demonstrates improvement over standard of care in 2L LB...
Dr Manali Kamdar - The University of Colorado Anschutz Medical Campus, Aurora, U...
Lisocabtagene maraleucel demonstrates improvement over standard of care in 2L LBCL ( Dr Manali Kamdar - The University of Colorado Anschutz Medical Campus, Aurora, USA )
11 Dec 2021
OncoAlert and ecancer weekly round up for November 29th - December 5th, 2021
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly round up for November 29th - December 5th, 2021 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
8 Dec 2021
Treating late relapse of paediatric ALL
Dr Arend von Stackelberg - Charité Universitätsmedizin, Berlin, Germany
Treating late relapse of paediatric ALL ( Dr Arend von Stackelberg - Charité Universitätsmedizin, Berlin, Germany )
2 Dec 2021
Cancer drug policy and access in LMICs
Dr Bishal Gyawali - Queen's University, Kingston, Canada
Cancer drug policy and access in LMICs ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )
26 Nov 2021
Latest in Philadelphia chromosome-positive ALL (Ph+ ALL)
Prof Robin Foà - Sapienza University of Rome, Rome, Italy
Latest in Philadelphia chromosome-positive ALL (Ph+ ALL) ( Prof Robin Foà - Sapienza University of Rome, Rome, Italy )
11 Nov 2021
OncoAlert and ecancer weekly round up for October 18th - October 23rd, 2021
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly round up for October 18th - October 23rd, 2021 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
26 Oct 2021
Advances in prostate cancer in the last 10 years and a glimpse to the future
Prof Laura-Maria Krabbe, Prof Karim Fizazi and Prof Johann De Bono
Advances in prostate cancer in the last 10 years and a glimpse to the future ( Prof Laura-Maria Krabbe, Prof Karim Fizazi and Prof Johann De Bono )
21 Oct 2021
OncoAlert and ecancer weekly round up for October 11th - October 16, 2021
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly round up for October 11th - October 16, 2021 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
18 Oct 2021
Nivolumab plus chemotherapy or ipilimumab vs chemotherapy as first-line treatmen...
Dr Yelena Janjigian - Memorial Sloan Kettering Center, New York, USA
Nivolumab plus chemotherapy or ipilimumab vs chemotherapy as first-line treatment for gastric cancers ( Dr Yelena Janjigian - Memorial Sloan Kettering Center, New York, USA )
14 Oct 2021